Diker Management’s Vyant Bio VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-429
Closed -$7K – 37
2019
Q3
$7K Hold
429
– – ﹤0.01% 32
2019
Q2
$10K Hold
429
– – ﹤0.01% 34
2019
Q1
$15K Hold
429
– – 0.01% 37
2018
Q4
$16K Hold
429
– – 0.01% 52
2018
Q3
$67K Hold
429
– – 0.02% 53
2018
Q2
$57K Hold
429
– – 0.02% 51
2018
Q1
$106K Sell
429
-18
-4% -$5.07K 0.04% 56
2017
Q4
$124K Hold
447
– – 0.04% 60
2017
Q3
$181K Buy
447
+12
+3% +$6.26K 0.07% 56
2017
Q2
$258K Buy
435
+13
+3% +$7.6K 0.11% 52
2017
Q1
$260K Buy
422
+177
+72% +$63K 0.12% 53
2016
Q4
$50K Buy
245
+46
+23% +$10.5K 0.02% 60
2016
Q3
$52K Hold
199
– – 0.02% 62
2016
Q2
$59K Hold
199
– – 0.02% 61
2016
Q1
$85K Buy
199
+7
+4% +$2.62K 0.03% 55
2015
Q4
$95K Hold
192
– – 0.03% 77
2015
Q3
$225K Hold
192
– – 0.05% 99
2015
Q2
$339K Buy
192
+39
+25% +$60.6K 0.06% 109
2015
Q1
$180K Sell
153
-80
-34% -$94.7K 0.03% 114
2014
Q4
$234K Buy
233
+33
+17% +$33.1K 0.05% 94
2014
Q3
$270K Buy
200
+18
+10% +$25.8K 0.05% 88
2014
Q2
$308K Buy
182
+36
+25% +$68.5K 0.07% 87
2014
Q1
$331K Buy
146
+69
+90% +$177K 0.07% 88
2013
Q4
$158K Buy
+77
New +$166K 0.04% 90

Other funds holding VYNT

Diker Management's VYNT Position: Q4 2019 in Review

Diker Management sold out of Vyant Bio (VYNT) in Q4 2019, closing a stake of 429 shares — an estimated $7K sold.

Diker Management first reported a position in VYNT in Q4 2013 and held it in 24 quarters. The position peaked at $339K in Q2 2015. 18 funds tracked by Wall St. Rank hold VYNT as of Q4 2019.

  • Diker Management reported no remaining Vyant Bio position as of Q4 2019 after selling out during the quarter.
  • Diker Management sold 429 Vyant Bio shares in Q4 2019, an estimated $7K.
  • Diker Management first reported a position in Vyant Bio in Q4 2013 and held it in 24 quarters.
  • Diker Management's Vyant Bio position peaked at $339K in Q2 2015.
  • 18 funds tracked by Wall St. Rank held Vyant Bio as of Q4 2019.

Based on Diker Management's 13F filing for Q4 2019, filed 14 Feb 2020.